Ireland is not currently experiencing an increase in meningococcal disease, including meningitis, despite a recent outbreak in the United Kingdom, health officials have confirmed. The Health Service Executive (HSE) stated on Thursday, March 19, 2026, that surveillance data shows disease activity remains at expected seasonal levels, and there is no indication of a link between cases in Ireland and the outbreak centered in Kent, England. This reassurance comes as public health authorities in the UK grapple with a growing cluster of cases, including two fatalities.
The HSE’s National Director for Public Health, Dr. John Cuddihy, emphasized that “there is no evidence of an increase” in invasive meningococcal disease activity in Ireland. According to RTÉ, Dr. Cuddihy also stated there is “currently no indication of links between any cases in Ireland and the outbreak reported in Kent.” Meningococcal disease is a bacterial infection that can lead to serious complications, including meningitis – inflammation of the brain and spinal cord – and septicaemia, or blood poisoning.
UK Outbreak and Response
The situation in the UK is more concerning. As of March 19, 2026, health authorities have confirmed 15 laboratory cases linked to the outbreak in Kent, with a further 12 cases under investigation, totaling 27 potential cases. Tragically, two young people have died as a result of the outbreak. The UK Health Security Agency (UKHSA) has indicated that the situation is evolving and further cases are possible. RTÉ reports that thousands of doses of antibiotics have been distributed to students at the University of Kent in Canterbury, and approximately 5,000 students have been invited to receive the MenB vaccine.
Ireland’s Vaccination Program and Monitoring
Ireland has a robust vaccination program in place to protect against meningococcal disease. Dr. Lucy Jessop, director of the HSE’s National Immunisation Office, explained that the MenB vaccine is included in the national childhood immunisation schedule for babies born on or after October 1, 2016, administered in three doses at 2, 4, and 12 months of age. This is particularly important as meningococcal type B disease is most common in infants under one year classic. There is currently no catch-up program for older children.
In addition to the MenB vaccine, the MenC vaccine is also offered to babies as part of the Primary Childhood Immunisation Programme. For older students, the MenACWY vaccine is administered in the first year of secondary school, providing protection against strains A, C, W, and Y. The HSE school immunisation teams are currently administering this vaccine nationwide, and parents are encouraged to return consent forms sent home with their children. Dr. Cuddihy graduated from University College Cork, Ireland, and has a long history of public health work within the HSE, including roles as Director of Health Protection Surveillance Centre (HPSC) and National Clinical Director of Health Protection, as noted in Patient Solutions.
Recognizing the Symptoms
Early recognition of symptoms is crucial when it comes to meningococcal disease. Dr. Cuddihy advised that symptoms can include fever, severe headache, vomiting, rapid breathing, cold hands and feet, drowsiness, and a rash that doesn’t fade under pressure. He stressed the importance of seeking immediate medical attention if someone is unwell and their condition is worsening, stating, “Do not wait for a rash. If someone is ill and getting worse, acquire medical aid immediately.”
The bacteria responsible for meningococcal disease have several different serotypes, each requiring a specific vaccine. Vaccines are available to protect against types A, B, C, W, and Y. The HSE continues to maintain regular contact with the UK Health Security Agency (UKHSA) to monitor the evolving situation in the UK and assess any potential risk to Ireland.
Routine surveillance in Ireland consistently demonstrates that meningococcal disease remains a rare, though serious, infection, with sporadic cases occurring each year. The HSE emphasizes the importance of staying informed and seeking medical advice if you are concerned about potential symptoms.
The HSE will continue to monitor the situation closely and provide updates as needed. The next update from the HSE regarding the UK outbreak and its potential impact on Ireland is expected in early April.
Please share this information with your community and stay informed about public health updates. If you have concerns about your health or the health of a loved one, consult with a healthcare professional.
